Kai-Xin-San Has Antidepressant-Like Effect in Tricyclic Antidepressant Treatment Resistant Animal Model by Rebalancing Tryptophan Metabolism.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Chinese Journal of Integrative Medicine

• Publication date

  2025-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11655-025-3935-5PMID 40938503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kai-Xin-San ameliorates fluoxetine-resistant depressive-like behaviors by modulating tryptophan-kynurenine metabolic homeostasis in a rodent model.

  2025cited by this paper
• Treatment-resistant depression: molecular mechanisms and management

  2024cited by this paper
• The Therapeutic Effects of Saikosaponins on Depression through the Modulation of Neuroplasticity: From Molecular Mechanisms to Potential Clinical Applications.

  2024cited by this paper
• Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).

  2024cited by this paper
• Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression.

  2024cited by this paper
• Constituents, pharmacological activities, pharmacokinetic studies, clinical applications, and safety profile on the classical prescription Kaixinsan

  2024cited by this paper
• Xiangshao Granules Ameliorate Post-stroke Depression by Inhibiting Activation of Microglia and IDO1 Expression in Hippocampus and Prefrontal Cortex

  2024cited by this paper
• Biological correlates of treatment resistant depression: a review of peripheral biomarkers

  2023cited by this paper
• Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis.

  2023cited by this paper
• Pharmacotherapy: Ketamine and Esketamine.

  2023cited by this paper
• Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms

  2022cited by this paper
• Role of 5-HT1A-mediated upregulation of brain indoleamine 2,3 dioxygenase 1 in the reduced antidepressant and antihyperalgesic effects of fluoxetine during maintenance treatment

  2022cited by this paper
• KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats

  2022cited by this paper
• Comprehensive Quality Assessment of Kaixin Powder by HPLC–DAD Quantification and HPLC–QTOF-MS/MS Confirmation

  2021cited by this paper
• The effects of KaiXinSan on depression and its association with lipid profiles: A randomized, double-blinded, placebo-controlled trial.

  2021cited by this paper
• Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells

  2021cited by this paper
• The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes.

  2021cited by this paper
• Novel insights into antidepressant mechanism of Kai Xin San formula: Inhibiting NLRP3 inflammasome activation by promoting autophagy.

  2021cited by this paper
• Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system.

  2020cited by this paper
• A randomized, placebo-controlled, double-blind study on the effects of SZL on patients with mild to moderate depressive disorder with comparison to fluoxetine.

  2020cited by this paper
• Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression

  2020cited by this paper
• Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.

  2019cited by this paper
• Combination of Geniposide and Eleutheroside B Exerts Antidepressant-like Effect on Lipopolysaccharide-Induced Depression Mice Model

  2019cited by this paper
• Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone

  2019cited by this paper
• Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.

  2018cited by this paper
• Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy

  2018cited by this paper
• Characterization of the adrenocorticotrophic hormone ‐ induced mouse model of resistance to antidepressant drug treatment

  2017cited by this paper
• Tryptophan depletion affects compulsive behaviour in rats: strain dependent effects and associated neuromechanisms

  2017cited by this paper
• New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.

  2016cited by this paper
• Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.

  2016cited by this paper
• Pharmacological approaches to the challenge of treatment-resistant depression

  2015cited by this paper
• Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice.

  2015cited by this paper
• Behavioral and biochemical effects of a formulation of the traditional Chinese medicine, Kai-Xin-San, in fatigued rats

  2013cited by this paper
• Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test.

  2002cited by this paper

• No citing papers are available for this paper.